International Assets Investment Management LLC Invests $4.24 Million in Encompass Health Co. (NYSE:EHC)

International Assets Investment Management LLC purchased a new stake in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund purchased 43,883 shares of the company's stock, valued at approximately $4,241,000.

Other institutional investors have also recently modified their holdings of the company. Commonwealth Equity Services LLC lifted its position in Encompass Health by 1.3% during the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company's stock valued at $845,000 after purchasing an additional 123 shares during the period. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after buying an additional 140 shares during the last quarter. O Shaughnessy Asset Management LLC lifted its holdings in shares of Encompass Health by 3.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 4,246 shares of the company's stock valued at $351,000 after buying an additional 160 shares during the period. Mount Yale Investment Advisors LLC boosted its stake in shares of Encompass Health by 6.6% in the second quarter. Mount Yale Investment Advisors LLC now owns 2,749 shares of the company's stock worth $236,000 after buying an additional 170 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. grew its holdings in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after acquiring an additional 198 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

EHC has been the topic of several recent research reports. Leerink Partners began coverage on Encompass Health in a research report on Wednesday, July 10th. They issued an "outperform" rating and a $100.00 price objective on the stock. Truist Financial reissued a "buy" rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday. Stephens reaffirmed an "overweight" rating and issued a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research note on Tuesday. Finally, Barclays lifted their price target on Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a research note on Tuesday. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $107.11.

Encompass Health Price Performance

NYSE:EHC traded down $0.55 during trading hours on Friday, hitting $98.91. 771,681 shares of the stock were exchanged, compared to its average volume of 640,710. The firm's fifty day moving average price is $94.47 and its 200 day moving average price is $88.88. Encompass Health Co. has a 52-week low of $62.58 and a 52-week high of $102.36. The company has a market cap of $9.95 billion, a P/E ratio of 23.89, a P/E/G ratio of 1.47 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.35 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the company earned $0.86 EPS. The firm's revenue was up 11.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.27 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 0.69%. Encompass Health's payout ratio is presently 16.43%.

Encompass Health announced that its board has initiated a stock repurchase program on Wednesday, July 24th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to buy up to 5.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.

Insider Activity at Encompass Health

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the business's stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the transaction, the chief financial officer now owns 136,227 shares of the company's stock, valued at approximately $11,761,839.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 2.10% of the stock is owned by corporate insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.